Cargando…

Clinical pharmacokinetics of antiretroviral drugs in Ugandan patients

Clinical pharmacokinetic data on antiretroviral drugs are scarce in African HIV-1-positive patients. Most available pharmacokinetic data are derived from ethnically distinct Caucasian research volunteers. This presentation will focus on the clinical pharmacokinetics training and research outputs of...

Descripción completa

Detalles Bibliográficos
Autor principal:	Lamorde, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2012
Materias:	Oral Abstract – O141
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512449/ http://dx.doi.org/10.7448/IAS.15.6.18079

Ejemplares similares

From guidelines to action: implementation opportunities and realities
por: El-Sadr, Wafaa
Publicado: (2014)

Profil clinique et paraclinique chez les patients asthmatiques atteints d’infection COVID-19
por: Kaouane, H., et al.
Publicado: (2022)

Séroprévalence du SARS-CoV-2 parmi la population générale de Tunis, mars-avril 2021
por: Cherif, I., et al.
Publicado: (2022)

PÚRPURA TROMBOCITOPÊNICA IMUNE SECUNDÁRIA À INFECÇÃO POR CORONAVÍRUS SARS-COV2: RELATO DE CASO
por: Rocha, A.Q.A.
Publicado: (2020)

Evolution of resistance in paediatric patients with failure on antiretroviral therapy
por: Orrell, C, et al.
Publicado: (2012)

Relationships between respiratory parameters and quadriceps strength in subjects with chronic obstructive pulmonary disease
por: Mahassine, Gabriel, et al.
Publicado: (2021)

Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implant
por: Scarsi, Kimberly, et al.
Publicado: (2014)

Life expectancy of HIV-1-positive individuals approaches normal conditional on response to antiretroviral therapy: UK Collaborative HIV Cohort Study
por: May, M, et al.
Publicado: (2012)

Effectiveness of a reduced dose of efavirenz plus 2 NRTIs as maintenance antiretroviral therapy with the guidance of therapeutic drug monitoring
por: Yang, Shang-Ping, et al.
Publicado: (2014)

Darunavir pharmacokinetics throughout pregnancy and postpartum
por: Lambert, John, et al.
Publicado: (2014)

HIV drug resistance surveillance in low- and middle-income countries: 2004 to 2010
por: Bertagnolio, S, et al.
Publicado: (2012)

Predicted savings to the UK National Health Service from switching to generic antiretrovirals, 2014–2018
por: Hill, Andrew, et al.
Publicado: (2014)

Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infection
por: Thornhill, John, et al.
Publicado: (2014)

Everything fine so far? Physical and mental health in HIV-infected patients with virological success and long-term exposure to antiretroviral therapy
por: Erdbeer, Gesa, et al.
Publicado: (2014)

Management of drug-resistant TB in patients with HIV co-infection
por: Meintjes, Graeme
Publicado: (2014)

When to start: as soon as possible
por: Saag, M
Publicado: (2012)

Does early initiation of ART in infants affect virological and resistance outcomes? Data from the CHER trial after 6 years of follow-up
por: Violari, A, et al.
Publicado: (2012)

Currently available medications may not be sufficient for lifelong treatment of HIV
por: Jansson, J, et al.
Publicado: (2012)

Antiviral activity of dolutegravir in subjects with failure on an integrase inhibitor-based regimen: week 24 phase 3 results from VIKING-3
por: Nichols, G, et al.
Publicado: (2012)

When to start: not so fast
por: Lundgren, J
Publicado: (2012)

Late presenters: what can we do?
por: Mussini, C
Publicado: (2012)

TB and HIV: how can we reduce mortality?
por: Lawn, S
Publicado: (2012)

Treatment optimization in low- and middle-income countries
por: Cooper, D
Publicado: (2012)

HIV, co-morbidity and ageing
por: Reiss, P
Publicado: (2012)

Eliminating paediatric infections and keeping mothers alive
por: Gray, G
Publicado: (2012)

Review of life expectancy in people with HIV in settings with optimal ART access: what we know and what we don't
por: Sabin, C
Publicado: (2012)

HIV in women
por: Mulcahy, F
Publicado: (2012)

HAART rollout in the new fiscal and economic environment
por: Moatti, J
Publicado: (2012)

Safety profile of HIV-1 attachment inhibitor prodrug BMS-663068 in antiretroviral-experienced subjects: week 24 analysis
por: Lalezari, Jacob, et al.
Publicado: (2014)

HIV-1 attachment inhibitor prodrug BMS-663068 in antiretroviral-experienced subjects: week 24 sub-group analysis
por: Brinson, Cynthia, et al.
Publicado: (2014)

Drug use, HIV, HCV and TB: major interlinked challenges in Eastern Europe and Central Asia
por: Kazatchkine, Michel
Publicado: (2014)

Major challenges in clinical management of TB/HIV co-infected patients in Eastern Europe compared with Western Europe and Latin America
por: Efsen, Anne Marie, et al.
Publicado: (2014)

A clinically useful risk-score for chronic kidney disease in HIV infection
por: Mocroft, Amanda, et al.
Publicado: (2014)

The R263K mutation in HIV integrase that is selected by dolutegravir may actually prevent clinically relevant resistance to this compound
por: Wainberg, Mark, et al.
Publicado: (2014)

Enhancing patient self-management
por: Volny-Anne, Alain
Publicado: (2014)

Forty-eight-week efficacy and safety and early CNS tolerability of doravirine (MK-1439), a novel NNRTI, with TDF/FTC in ART-naive HIV-positive patients
por: Gatell, Josep M, et al.
Publicado: (2014)

Cost-effectiveness analysis of protease inhibitor monotherapy vs. ongoing triple-therapy in the long-term management of HIV patients
por: Oddershede, Lars, et al.
Publicado: (2014)

Cardiovascular risk evaluation of HIV-positive patients in a case-control study: comparison of the D:A:D and Framingham equations
por: Markowicz, Samuel, et al.
Publicado: (2014)

CD4+ cell count recovery in naïve patients initiating cART, who achieved and maintained plasma HIV-RNA suppression
por: Costagliola, Dominique, et al.
Publicado: (2014)

Safety and efficacy of ombitasvir – 450/r and dasabuvir and ribavirin in HCV/HIV-1 co-infected patients receiving atazanavir or raltegravir ART regimens
por: Eron, Joseph J, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rgtlglrak2uhj36r034dg9rsn4